Kendall Hunter
Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Artery | 33 | 2024 | 1086 | 3.830 |
Why?
| | Hypertension, Pulmonary | 37 | 2023 | 1910 | 3.130 |
Why?
| | Ventricular Dysfunction, Right | 14 | 2023 | 238 | 3.120 |
Why?
| | Ventricular Function, Right | 21 | 2024 | 285 | 3.070 |
Why?
| | Heart Ventricles | 23 | 2024 | 788 | 2.840 |
Why?
| | Vascular Stiffness | 25 | 2023 | 494 | 2.330 |
Why?
| | Models, Cardiovascular | 13 | 2020 | 198 | 1.710 |
Why?
| | Pulmonary Circulation | 13 | 2022 | 429 | 1.430 |
Why?
| | Stroke Volume | 15 | 2023 | 612 | 1.270 |
Why?
| | Magnetic Resonance Imaging, Cine | 12 | 2023 | 193 | 1.210 |
Why?
| | Blood Pressure | 12 | 2021 | 1786 | 1.040 |
Why?
| | Arterial Pressure | 5 | 2019 | 126 | 0.960 |
Why?
| | Hemodynamics | 16 | 2023 | 1113 | 0.950 |
Why?
| | Vascular Resistance | 11 | 2022 | 375 | 0.940 |
Why?
| | Echocardiography, Three-Dimensional | 2 | 2023 | 50 | 0.920 |
Why?
| | Cardiac Catheterization | 13 | 2021 | 530 | 0.920 |
Why?
| | Fontan Procedure | 6 | 2023 | 180 | 0.890 |
Why?
| | Echocardiography | 10 | 2024 | 642 | 0.890 |
Why?
| | Imaging, Three-Dimensional | 4 | 2013 | 580 | 0.810 |
Why?
| | Phantoms, Imaging | 2 | 2014 | 152 | 0.770 |
Why?
| | Magnetic Resonance Angiography | 4 | 2019 | 240 | 0.750 |
Why?
| | Magnetic Resonance Imaging | 13 | 2024 | 3566 | 0.740 |
Why?
| | Blood Flow Velocity | 8 | 2019 | 413 | 0.730 |
Why?
| | Forecasting | 1 | 2021 | 389 | 0.630 |
Why?
| | Carotid Arteries | 3 | 2018 | 206 | 0.580 |
Why?
| | Heart Defects, Congenital | 5 | 2024 | 842 | 0.560 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 69 | 0.550 |
Why?
| | Computer Simulation | 9 | 2019 | 978 | 0.530 |
Why?
| | Aorta, Thoracic | 6 | 2023 | 267 | 0.500 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 7 | 0.490 |
Why?
| | Collagen | 6 | 2014 | 452 | 0.480 |
Why?
| | Elastic Modulus | 4 | 2013 | 123 | 0.450 |
Why?
| | Aorta | 6 | 2020 | 417 | 0.450 |
Why?
| | Child | 33 | 2023 | 21935 | 0.430 |
Why?
| | Hypoxia | 5 | 2024 | 1112 | 0.410 |
Why?
| | Fetal Growth Retardation | 3 | 2013 | 565 | 0.400 |
Why?
| | Male | 51 | 2025 | 67762 | 0.400 |
Why?
| | Cattle | 10 | 2023 | 984 | 0.390 |
Why?
| | Heart-Assist Devices | 4 | 2021 | 552 | 0.390 |
Why?
| | Portal Vein | 1 | 2014 | 120 | 0.390 |
Why?
| | Industry | 1 | 2013 | 68 | 0.390 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 43 | 0.380 |
Why?
| | Tetralogy of Fallot | 1 | 2012 | 79 | 0.380 |
Why?
| | Placental Insufficiency | 1 | 2013 | 116 | 0.360 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 332 | 0.350 |
Why?
| | Humans | 66 | 2024 | 137585 | 0.350 |
Why?
| | Adolescent | 25 | 2023 | 21513 | 0.330 |
Why?
| | Myocardial Contraction | 4 | 2020 | 341 | 0.330 |
Why?
| | Female | 46 | 2025 | 73304 | 0.330 |
Why?
| | Elasticity | 6 | 2015 | 197 | 0.330 |
Why?
| | Blood Pressure Determination | 2 | 2008 | 157 | 0.330 |
Why?
| | Extracellular Matrix | 5 | 2021 | 528 | 0.330 |
Why?
| | Pulse Wave Analysis | 6 | 2023 | 272 | 0.320 |
Why?
| | Ventricular Function, Left | 5 | 2023 | 534 | 0.320 |
Why?
| | Predictive Value of Tests | 9 | 2023 | 2031 | 0.320 |
Why?
| | Heart Failure | 5 | 2023 | 2236 | 0.320 |
Why?
| | Ultrasonography | 1 | 2013 | 759 | 0.310 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2020 | 121 | 0.290 |
Why?
| | Aortic Diseases | 2 | 2021 | 119 | 0.290 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2021 | 752 | 0.290 |
Why?
| | Stress, Physiological | 1 | 2012 | 443 | 0.290 |
Why?
| | Fetus | 1 | 2013 | 806 | 0.290 |
Why?
| | Image Interpretation, Computer-Assisted | 4 | 2018 | 267 | 0.280 |
Why?
| | Stress, Mechanical | 9 | 2019 | 485 | 0.280 |
Why?
| | Retrospective Studies | 18 | 2023 | 15657 | 0.280 |
Why?
| | Elastin | 6 | 2015 | 78 | 0.270 |
Why?
| | Infant | 12 | 2021 | 9465 | 0.270 |
Why?
| | Case-Control Studies | 13 | 2019 | 3556 | 0.260 |
Why?
| | Heart Septal Defects | 1 | 2006 | 8 | 0.260 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 1040 | 0.260 |
Why?
| | Cardiac Output | 4 | 2020 | 165 | 0.260 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2019 | 382 | 0.260 |
Why?
| | Vasomotor System | 1 | 2006 | 47 | 0.250 |
Why?
| | Regional Blood Flow | 4 | 2021 | 474 | 0.230 |
Why?
| | Child, Preschool | 14 | 2023 | 11074 | 0.230 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5131 | 0.230 |
Why?
| | Reproducibility of Results | 7 | 2018 | 3284 | 0.220 |
Why?
| | Arteries | 2 | 2018 | 269 | 0.220 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2691 | 0.220 |
Why?
| | Heart Transplantation | 2 | 2023 | 754 | 0.210 |
Why?
| | Models, Biological | 1 | 2011 | 1783 | 0.210 |
Why?
| | Animals | 22 | 2025 | 36940 | 0.210 |
Why?
| | Myocardium | 3 | 2023 | 1002 | 0.210 |
Why?
| | Patient-Specific Modeling | 3 | 2020 | 41 | 0.200 |
Why?
| | Materials Testing | 2 | 2017 | 356 | 0.200 |
Why?
| | Electrocardiography | 2 | 2023 | 629 | 0.200 |
Why?
| | Endothelial Cells | 3 | 2023 | 785 | 0.190 |
Why?
| | Umbilical Arteries | 2 | 2013 | 55 | 0.190 |
Why?
| | Severity of Illness Index | 6 | 2019 | 2828 | 0.190 |
Why?
| | Prospective Studies | 9 | 2021 | 7604 | 0.190 |
Why?
| | Perfusion Imaging | 2 | 2019 | 58 | 0.180 |
Why?
| | Assisted Circulation | 1 | 2021 | 26 | 0.180 |
Why?
| | Sensitivity and Specificity | 4 | 2018 | 1946 | 0.180 |
Why?
| | Glycopeptides | 1 | 2021 | 43 | 0.170 |
Why?
| | Arrhythmias, Cardiac | 1 | 2023 | 333 | 0.170 |
Why?
| | Exercise | 2 | 2024 | 2057 | 0.170 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2021 | 99 | 0.170 |
Why?
| | Adipose Tissue | 1 | 2025 | 635 | 0.170 |
Why?
| | Ventricular Pressure | 1 | 2019 | 48 | 0.160 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 2111 | 0.160 |
Why?
| | Peptide Fragments | 2 | 2021 | 706 | 0.160 |
Why?
| | Disease Models, Animal | 7 | 2023 | 4295 | 0.160 |
Why?
| | Oxygen Consumption | 2 | 2024 | 696 | 0.150 |
Why?
| | Age Factors | 5 | 2019 | 3295 | 0.150 |
Why?
| | Marfan Syndrome | 1 | 2018 | 41 | 0.150 |
Why?
| | Sheep | 4 | 2014 | 856 | 0.150 |
Why?
| | Lung | 5 | 2015 | 4060 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 530 | 0.140 |
Why?
| | Neuroendocrine Cells | 1 | 2018 | 32 | 0.140 |
Why?
| | Turner Syndrome | 1 | 2018 | 54 | 0.140 |
Why?
| | Microcirculation | 2 | 2016 | 149 | 0.140 |
Why?
| | Models, Theoretical | 2 | 2013 | 578 | 0.140 |
Why?
| | Thermodilution | 1 | 2017 | 13 | 0.140 |
Why?
| | Cardiorespiratory Fitness | 1 | 2018 | 55 | 0.140 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 82 | 0.140 |
Why?
| | Prognosis | 5 | 2019 | 4030 | 0.140 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 108 | 0.140 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 91 | 0.130 |
Why?
| | Aortic Coarctation | 1 | 2018 | 83 | 0.130 |
Why?
| | Shear Strength | 3 | 2018 | 67 | 0.130 |
Why?
| | ROC Curve | 2 | 2015 | 554 | 0.130 |
Why?
| | Algorithms | 4 | 2019 | 1704 | 0.130 |
Why?
| | Hemorheology | 1 | 2016 | 22 | 0.130 |
Why?
| | Pressure | 2 | 2019 | 225 | 0.130 |
Why?
| | Glycocalyx | 1 | 2016 | 27 | 0.130 |
Why?
| | Biomimetic Materials | 1 | 2017 | 72 | 0.120 |
Why?
| | Arterioles | 1 | 2016 | 52 | 0.120 |
Why?
| | Adaptation, Physiological | 2 | 2018 | 553 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 915 | 0.120 |
Why?
| | Physical Conditioning, Animal | 1 | 2018 | 257 | 0.120 |
Why?
| | Capillaries | 1 | 2016 | 108 | 0.120 |
Why?
| | Principal Component Analysis | 3 | 2023 | 195 | 0.120 |
Why?
| | Compliance | 2 | 2012 | 49 | 0.120 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2021 | 198 | 0.120 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2022 | 3715 | 0.110 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2017 | 261 | 0.110 |
Why?
| | Area Under Curve | 1 | 2015 | 314 | 0.110 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2023 | 145 | 0.110 |
Why?
| | Endotoxins | 1 | 2015 | 220 | 0.110 |
Why?
| | Animals, Newborn | 3 | 2015 | 844 | 0.110 |
Why?
| | Tissue Scaffolds | 1 | 2017 | 211 | 0.110 |
Why?
| | Adventitia | 1 | 2014 | 40 | 0.110 |
Why?
| | Pulsatile Flow | 1 | 2014 | 60 | 0.110 |
Why?
| | Young Adult | 8 | 2021 | 13209 | 0.110 |
Why?
| | Image Enhancement | 1 | 2015 | 190 | 0.110 |
Why?
| | Bronchi | 1 | 2015 | 260 | 0.110 |
Why?
| | Software | 2 | 2023 | 665 | 0.110 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 446 | 0.110 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 8 | 0.110 |
Why?
| | Contrast Media | 1 | 2017 | 467 | 0.110 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 46 | 0.110 |
Why?
| | Toll-Like Receptor 2 | 1 | 2014 | 115 | 0.100 |
Why?
| | Time Factors | 4 | 2021 | 6828 | 0.100 |
Why?
| | Oscillometry | 1 | 2013 | 42 | 0.100 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2014 | 137 | 0.100 |
Why?
| | Precision Medicine | 1 | 2017 | 429 | 0.100 |
Why?
| | Polymers | 1 | 2017 | 490 | 0.100 |
Why?
| | Ultrasonography, Doppler, Color | 2 | 2010 | 39 | 0.100 |
Why?
| | Pilot Projects | 3 | 2021 | 1710 | 0.100 |
Why?
| | Middle Aged | 9 | 2021 | 33479 | 0.090 |
Why?
| | Equipment Design | 1 | 2014 | 522 | 0.090 |
Why?
| | Vitamin D | 1 | 2015 | 397 | 0.090 |
Why?
| | Vasodilation | 3 | 2025 | 499 | 0.090 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 638 | 0.090 |
Why?
| | Reference Values | 2 | 2017 | 816 | 0.090 |
Why?
| | Models, Statistical | 1 | 2015 | 669 | 0.090 |
Why?
| | Elastic Tissue | 1 | 2011 | 9 | 0.090 |
Why?
| | Feasibility Studies | 1 | 2015 | 956 | 0.090 |
Why?
| | Fibrillar Collagens | 1 | 2011 | 13 | 0.090 |
Why?
| | Linear Models | 2 | 2018 | 849 | 0.090 |
Why?
| | Pre-Eclampsia | 1 | 2013 | 190 | 0.090 |
Why?
| | Rats, Wistar | 2 | 2025 | 455 | 0.090 |
Why?
| | MicroRNAs | 1 | 2017 | 692 | 0.090 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2010 | 7 | 0.080 |
Why?
| | Pregnancy | 5 | 2015 | 6763 | 0.080 |
Why?
| | NF-kappa B | 1 | 2014 | 691 | 0.080 |
Why?
| | Biomarkers | 2 | 2021 | 4149 | 0.080 |
Why?
| | Biomechanical Phenomena | 4 | 2017 | 810 | 0.080 |
Why?
| | Rats | 4 | 2025 | 5647 | 0.080 |
Why?
| | Vasodilator Agents | 1 | 2011 | 331 | 0.080 |
Why?
| | Uncertainty | 1 | 2010 | 128 | 0.080 |
Why?
| | Ultrasonics | 1 | 2009 | 49 | 0.080 |
Why?
| | Microbubbles | 1 | 2009 | 49 | 0.080 |
Why?
| | Exercise Test | 2 | 2024 | 625 | 0.080 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 145 | 0.080 |
Why?
| | Ventricular Remodeling | 2 | 2023 | 266 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2531 | 0.080 |
Why?
| | Mechanotransduction, Cellular | 2 | 2023 | 111 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2020 | 2654 | 0.070 |
Why?
| | Fibrosis | 2 | 2021 | 552 | 0.070 |
Why?
| | Reference Standards | 1 | 2008 | 186 | 0.070 |
Why?
| | Logistic Models | 2 | 2015 | 2074 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 124 | 0.070 |
Why?
| | Electric Impedance | 1 | 2007 | 107 | 0.070 |
Why?
| | Risk Factors | 3 | 2017 | 10388 | 0.070 |
Why?
| | Probability | 1 | 2007 | 304 | 0.060 |
Why?
| | Adipose Tissue, Brown | 1 | 2025 | 53 | 0.060 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2025 | 204 | 0.050 |
Why?
| | Protein-Losing Enteropathies | 1 | 2023 | 10 | 0.050 |
Why?
| | Chronic Disease | 1 | 2010 | 1793 | 0.050 |
Why?
| | Disease Progression | 3 | 2018 | 2757 | 0.050 |
Why?
| | Hypertension | 2 | 2012 | 1295 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2018 | 10811 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 30 | 0.050 |
Why?
| | Glycosaminoglycans | 2 | 2013 | 83 | 0.050 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.050 |
Why?
| | Long Term Adverse Effects | 1 | 2021 | 12 | 0.050 |
Why?
| | ADAMTS4 Protein | 1 | 2021 | 16 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2019 | 5472 | 0.050 |
Why?
| | Heart Murmurs | 1 | 2021 | 14 | 0.050 |
Why?
| | Temperature | 1 | 2025 | 679 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 16 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2022 | 564 | 0.040 |
Why?
| | Vascular Remodeling | 1 | 2021 | 193 | 0.040 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 13 | 0.040 |
Why?
| | Coronary Circulation | 1 | 2020 | 143 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 688 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 452 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 558 | 0.040 |
Why?
| | Rabbits | 1 | 2019 | 794 | 0.040 |
Why?
| | Diastole | 1 | 2018 | 149 | 0.040 |
Why?
| | Mitochondria | 1 | 2025 | 948 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 152 | 0.040 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 21 | 0.040 |
Why?
| | Pediatrics | 1 | 2006 | 1101 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2015 | 2486 | 0.040 |
Why?
| | Hyperplasia | 1 | 2018 | 175 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2018 | 102 | 0.030 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 82 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 110 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 104 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 342 | 0.030 |
Why?
| | Aftercare | 1 | 2019 | 208 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1738 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 431 | 0.030 |
Why?
| | Heart Valve Diseases | 1 | 2018 | 151 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2017 | 62 | 0.030 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 104 | 0.030 |
Why?
| | Vasoconstriction | 1 | 2018 | 202 | 0.030 |
Why?
| | Education | 1 | 2017 | 108 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2020 | 413 | 0.030 |
Why?
| | Blood Viscosity | 1 | 2016 | 17 | 0.030 |
Why?
| | Heart | 1 | 2020 | 655 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 322 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2018 | 279 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1111 | 0.030 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2015 | 31 | 0.030 |
Why?
| | Capillary Permeability | 1 | 2016 | 145 | 0.030 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2016 | 77 | 0.030 |
Why?
| | Aortic Valve | 1 | 2018 | 351 | 0.030 |
Why?
| | Risk | 1 | 2018 | 912 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2017 | 263 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 261 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1316 | 0.030 |
Why?
| | Demography | 1 | 2015 | 291 | 0.030 |
Why?
| | Hematocrit | 1 | 2014 | 96 | 0.030 |
Why?
| | Tricuspid Valve | 1 | 2014 | 30 | 0.030 |
Why?
| | Aged | 3 | 2019 | 23961 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 232 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 147 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 327 | 0.030 |
Why?
| | Cardiomyopathies | 1 | 2017 | 350 | 0.030 |
Why?
| | Altitude Sickness | 1 | 2014 | 153 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 1972 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2014 | 6079 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2014 | 273 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 622 | 0.020 |
Why?
| | Adult | 3 | 2024 | 37929 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 843 | 0.020 |
Why?
| | Mice | 2 | 2021 | 17787 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2014 | 508 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 700 | 0.020 |
Why?
| | Species Specificity | 1 | 2011 | 585 | 0.020 |
Why?
| | Obesity | 1 | 2023 | 2992 | 0.020 |
Why?
| | Gestational Age | 1 | 2012 | 910 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4193 | 0.020 |
Why?
| | Hyperbaric Oxygenation | 1 | 2008 | 39 | 0.020 |
Why?
| | Tunica Media | 1 | 2007 | 38 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2008 | 570 | 0.020 |
Why?
| | Finite Element Analysis | 1 | 2007 | 75 | 0.020 |
Why?
| | Tunica Intima | 1 | 2007 | 84 | 0.020 |
Why?
| | Protein Conformation | 1 | 2008 | 934 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2012 | 2475 | 0.010 |
Why?
| | Radiography | 1 | 2007 | 822 | 0.010 |
Why?
| | Colorado | 1 | 2014 | 4565 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 5757 | 0.010 |
Why?
| | Research Design | 1 | 2010 | 1139 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2837 | 0.010 |
Why?
| | United States | 1 | 2017 | 14841 | 0.010 |
Why?
|
|
Hunter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|